Ledger.Open graph →
SEC Form D · Amendment · filed April 11, 2014

EIGER BIOPHARMACEUTICALS INC

Offering
$5.9M
Sold
$5.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Santa Clara, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

David Deutsch · New York, NYDirectorSridhar Bearelly · New York, NYExec · DirectorJacob Freifeld · Palo Alto, CADirectorTracy Overath · Austin, TXDirectorStuart Griffiths · Grand Cayman, Cayman IslandsExec · DirectorJason Vickers · Grand Cayman, Cayman IslandsDirectorJesper Poulsen · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗